| Financial Year |
March 31 2023 |
| Monetary Funds |
921,844,920.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,817,849.81 |
| Accounts Receivable |
1,534,459,772.36 |
| Advances to Suppliers |
196,860,650.32 |
| Other Receivables |
100,098,587.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
240,482,299.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
525,005,479.80 |
| Total Current Assets |
3,562,700,649.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,964,077.80 |
| Fixed Assetes |
1,477,888,838.19 |
| Under-construction Projects |
126,817,037.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,579,558,776.53 |
| R&D expenses |
127,966,906.02 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,350,325.52 |
| Deferred Income Tax Assets |
3,032,624.26 |
| Other Non-Current Assets |
20,746,701.48 |
| Sub-Total of Non-Current Assets |
3,453,315,309.90 |
| Total Assets |
7,016,015,959.89 |
| Short-Term Loans |
1,234,415,724.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,874,000.00 |
| Accounts Payable |
575,598,495.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,144,215.11 |
| Taxes Payable |
363,682,833.17 |
| Interest Payable |
11,708,143.50 |
| Dividend Payable |
-- |
| Other payables |
392,181,341.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
241,980,960.36 |
| Other Current Liabilities |
14,654,150.15 |
| Sub-Total of Current Liabilities |
3,027,994,644.61 |
| Long-term Loans |
1,564,411,292.60 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
160,309.77 |
| Deferred Income Tax Liabilities |
114,476,511.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,734,015,850.34 |
| Total Liabilities |
4,762,010,494.95 |
| Paid-In Capital(Or Share Stock) |
5,042,547,739.00 |
| Capital Surplus |
18,477,607,232.03 |
| Surplus Reserve |
336,107,090.51 |
| LESS:Treasury Stock |
321,321,103.00 |
| Undistributed Profits |
-21,285,640,436.15 |
| Minority Stockholder's Interest |
4,704,942.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,249,300,522.39 |
| Owner's Equity（Stockholder's Equity） |
2,254,005,464.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,016,015,959.89 |
